Nicholas W. Stine
Research Subjects
Nicholas W. Stine has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Dave A. Chokshi
CUNY Graduate School of Public Health and Health Policy, New York, New York
8 shared publications Abdulrahman M. El-Sayed
City of Detroit Department of Health and Wellness Promotion, Detroit, Michigan
2 shared publications- Marc. N. Gourevitch
Department of Population Health, New York University School of Medicine, New York, New York
2 shared publications - Ronald Scott Braithwaite
Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA
2 shared publications - Alexander R. Stine
Department of Earth & Climate Sciences, San Francisco State University, San Francisco, USA
1 shared publication Cristina M. Almeida
1 shared publication
Latest Publications
- 22 March 2016
- Published by American Medical Association (AMA)
- Vol. 315 (12) , 1288
Nonlinear Exposure-Outcome Associations and Public Health Policy—Reply
In Reply Dr Fraser and colleagues and Dr Kiran and colleagues underscore important methodologic issues surrounding J-shaped curves—particularly reverse causality and the need for rigorous research on the precise trajectories of exposure-outcome associations. We agree with Fraser and colleagues that improvements in causal inference methods are crucial to understanding the public health implications of interventions. However, we caution that instrumental variables may have some limitations in cases in which nonlinear exposure-outcome relationships actually exist. At issue is the assumption that the instrument itself has a linear effect on the exposure variable at all levels of the distribution. Therefore, investigators must ensure that instruments behave similarly at the extremes of the exposure distribution for these tools to be helpful in the setting of J-shaped curves.
- 22 March 2016
- Published by American Medical Association (AMA)
- Vol. 315 (12) , 1288
Nonlinear Exposure-Outcome Associations and Public Health Policy—Reply
In Reply Dr Fraser and colleagues and Dr Kiran and colleagues underscore important methodologic issues surrounding J-shaped curves—particularly reverse causality and the need for rigorous research on the precise trajectories of exposure-outcome associations. We agree with Fraser and colleagues that improvements in causal inference methods are crucial to understanding the public health implications of interventions. However, we caution that instrumental variables may have some limitations in cases in which nonlinear exposure-outcome relationships actually exist. At issue is the assumption that the instrument itself has a linear effect on the exposure variable at all levels of the distribution. Therefore, investigators must ensure that instruments behave similarly at the extremes of the exposure distribution for these tools to be helpful in the setting of J-shaped curves.
- Open Access
- 6 October 2015
- Published by American Medical Association (AMA) in JAMA
- Vol. 314 (13) , 1339-1340
J-Shaped Curves and Public Health
This Viewpoint discusses approaches to public health communication challenges posed by J-shaped associations between health effects and major modifiable risk fa
- 6 October 2015
- Published by American Medical Association (AMA) in JAMA
- Vol. 314 (13) , 1339-1340
Open AccessJ-Shaped Curves and Public Health
This Viewpoint discusses approaches to public health communication challenges posed by J-shaped associations between health effects and major modifiable risk fa
- 3 March 2015
- Published by American Medical Association (AMA)
- Vol. 313 (9) , 972
Multifactorial Risk Assessment for Atherosclerotic Cardiovascular Disease—Reply
In Reply Dr Zelicoff points to several significant challenges for the development and implementation of successful risk-based quality measures, including limitations of existing risk calculator tools and the ability of clinicians to interpret and communicate statistical risk. We share the sentiment that practical, standardized, and validated approaches to risk calculation and communication are a significant research and educational need. As Zelicoff effectively illustrates with the example of the FRAX tool for osteoporosis, best practice guidelines are imperfectly applied on the ground—perhaps more so when risk calculation is involved. Yet operational challenges should not lead to jettisoning of best practices. Rather, systems and policy solutions to facilitate a higher standard of care should be sought. In this way, we view the application of quality measures as a tool for driving improvement and promoting accountability, rather than merely a common denominator for assessment.
- 3 March 2015
- Published by American Medical Association (AMA)
- Vol. 313 (9) , 972
Multifactorial Risk Assessment for Atherosclerotic Cardiovascular Disease—Reply
In Reply Dr Zelicoff points to several significant challenges for the development and implementation of successful risk-based quality measures, including limitations of existing risk calculator tools and the ability of clinicians to interpret and communicate statistical risk. We share the sentiment that practical, standardized, and validated approaches to risk calculation and communication are a significant research and educational need. As Zelicoff effectively illustrates with the example of the FRAX tool for osteoporosis, best practice guidelines are imperfectly applied on the ground—perhaps more so when risk calculation is involved. Yet operational challenges should not lead to jettisoning of best practices. Rather, systems and policy solutions to facilitate a higher standard of care should be sought. In this way, we view the application of quality measures as a tool for driving improvement and promoting accountability, rather than merely a common denominator for assessment.
- 19 November 2014
- Published by American Medical Association (AMA) in JAMA
- Vol. 312 (19) , 1971-1972
Elimination of Lipid Levels From Quality Measures
This Viewpoint discusses the implications of recently updated guidelines that eliminate quality measures addressing lipid levels.
- 19 November 2014
- Published by American Medical Association (AMA) in JAMA
- Vol. 312 (19) , 1971-1972
Elimination of Lipid Levels From Quality Measures
This Viewpoint discusses the implications of recently updated guidelines that eliminate quality measures addressing lipid levels.
- 1 December 2013
- Published by Elsevier in Healthcare
- Vol. 1 (3-4) , 86-90
HALE and hearty: Toward more meaningful health measurement in the clinical setting
- 1 December 2013
- Published by Elsevier in Healthcare
- Vol. 1 (3-4) , 86-90
HALE and hearty: Toward more meaningful health measurement in the clinical setting
- Open Access
- 28 October 2013
- Published by Ubiquity Press, Ltd. in eGEMs (Generating Evidence & Methods to improve patient outcomes)
- Vol. 1 (2) , 1022
Health-weighted Composite Quality Metrics Offer Promise to Improve Health Outcomes in a Learning Health System
Health systems sometimes adopt quality metrics without robust supporting evidence of improvements in quality and/or quantity of life, which may impair rather than facilitate improved health outcomes. In brief, there is now no easy way to measure how much “health” is conferred by a health system. However, we argue that this goal is achievable. Health-weighted composite quality metrics have the potential to measure “health” by synthesizing individual evidence-based quality metrics into a summary measure, utilizing relative weightings that reflect the relative amount of health benefit conferred by each constituent quality metric. Previously, it has been challenging to create health-weighted composite quality metrics because of methodological and data limitations. However, advances in health information technology and mathematical modeling of disease progression promise to help mitigate these challenges by making patient-level data more accessible and more actionable for use. Accordingly, it may now be possible to use health information technology to calculate and track a health-weighted composite quality metric for each patient that reflects the health benefit conferred to that patient by the health system. These health-weighted composite quality metrics can be employed for a multitude of important aims that improve health outcomes, including quality evaluation, population health maximization, health disparity attenuation, panel management, resource allocation, and personalization of care. We describe the necessary attributes, the possible uses, and the likely limitations and challenges of health-weighted composite quality metrics.
- 28 October 2013
- Published by Ubiquity Press, Ltd. in eGEMs (Generating Evidence & Methods to improve patient outcomes)
- Vol. 1 (2) , 1022
Open AccessHealth-weighted Composite Quality Metrics Offer Promise to Improve Health Outcomes in a Learning Health System
Health systems sometimes adopt quality metrics without robust supporting evidence of improvements in quality and/or quantity of life, which may impair rather than facilitate improved health outcomes. In brief, there is now no easy way to measure how much “health” is conferred by a health system. However, we argue that this goal is achievable. Health-weighted composite quality metrics have the potential to measure “health” by synthesizing individual evidence-based quality metrics into a summary measure, utilizing relative weightings that reflect the relative amount of health benefit conferred by each constituent quality metric. Previously, it has been challenging to create health-weighted composite quality metrics because of methodological and data limitations. However, advances in health information technology and mathematical modeling of disease progression promise to help mitigate these challenges by making patient-level data more accessible and more actionable for use. Accordingly, it may now be possible to use health information technology to calculate and track a health-weighted composite quality metric for each patient that reflects the health benefit conferred to that patient by the health system. These health-weighted composite quality metrics can be employed for a multitude of important aims that improve health outcomes, including quality evaluation, population health maximization, health disparity attenuation, panel management, resource allocation, and personalization of care. We describe the necessary attributes, the possible uses, and the likely limitations and challenges of health-weighted composite quality metrics.
- 25 October 2013
- Published by National Academy of Medicine in NAM Perspectives
- Vol. 3 (10)
HALE - Unification Theory for Clinical Medicine and Population Health
- 25 October 2013
- Published by National Academy of Medicine in NAM Perspectives
- Vol. 3 (10)
HALE - Unification Theory for Clinical Medicine and Population Health
- 11 September 2013
- Published by American Medical Association (AMA) in JAMA
- Vol. 310 (10) , 1025-1026
Reconsidering the Politics of Public Health
A central dilemma in public health is reconciling the role of the individual with the role of the government in promoting health. On the one hand, governmental policy approaches—taxes, bans, and other regulations—are seen as emblematic of “nanny state” overreach. In this view, public health regulation is part of a slippery slope toward escalating government intrusion on individual liberty. On the other hand, regulatory policy is described as a fundamental instrument for a “savvy state” to combat the conditions underlying an inexorable epidemic of chronic diseases. Proponents of public health regulation cite the association of aggressive tobacco control, physical activity, and nutritional interventions with demonstrable increases in life expectancy.1
- 11 September 2013
- Published by American Medical Association (AMA) in JAMA
- Vol. 310 (10) , 1025-1026
Reconsidering the Politics of Public Health
A central dilemma in public health is reconciling the role of the individual with the role of the government in promoting health. On the one hand, governmental policy approaches—taxes, bans, and other regulations—are seen as emblematic of “nanny state” overreach. In this view, public health regulation is part of a slippery slope toward escalating government intrusion on individual liberty. On the other hand, regulatory policy is described as a fundamental instrument for a “savvy state” to combat the conditions underlying an inexorable epidemic of chronic diseases. Proponents of public health regulation cite the association of aggressive tobacco control, physical activity, and nutritional interventions with demonstrable increases in life expectancy.1
- 6 February 2013
- Published by American Medical Association (AMA) in JAMA
- Vol. 309 (5) , 449-116
Improving Population Health in US Cities
Thick-slice image acquisitions are sometimes inevitable in magnetic resonance imaging due to limitations posed by pulse sequence timing and signal-to-noise-ratio. The estimation of an isotropic high-resolution volume from thick-slice MRI scans is desired for improved...
- 6 February 2013
- Published by American Medical Association (AMA) in JAMA
- Vol. 309 (5) , 449-116
Improving Population Health in US Cities
Thick-slice image acquisitions are sometimes inevitable in magnetic resonance imaging due to limitations posed by pulse sequence timing and signal-to-noise-ratio. The estimation of an isotropic high-resolution volume from thick-slice MRI scans is desired for improved...
- 2 February 2012
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 366 (5) , 395-397
Opportunity in Austerity — A Common Agenda for Medicine and Public Health
Faced with the growing pressure to reduce the federal budget deficit, government leaders have increasingly turned their attention to reducing health expenditures. In this atmosphere of austerity, public health programs are likely to be hit particularly hard as they compete for funds against the health care delivery juggernaut and as state and local governments, which carry out the bulk of public health activities, are forced to make further cuts.
- 2 February 2012
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 366 (5) , 395-397
Opportunity in Austerity — A Common Agenda for Medicine and Public Health
Faced with the growing pressure to reduce the federal budget deficit, government leaders have increasingly turned their attention to reducing health expenditures. In this atmosphere of austerity, public health programs are likely to be hit particularly hard as they compete for funds against the health care delivery juggernaut and as state and local governments, which carry out the bulk of public health activities, are forced to make further cuts.